Onderneming ESSA Pharma Inc. Toronto S.E.
Aandelen
EPI
CA29668H7085
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 50
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 24-06-15 |
David Wood
DFI | Director of Finance/CFO | 66 | 01-10-13 |
Peter Virsik
COO | Chief Operating Officer | - | 01-08-16 |
Chief Tech/Sci/R&D Officer | 63 | 15-07-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 05-03-15 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 31-07-19 |
Richard Glickman
CHM | Chairman | 65 | 01-10-10 |
Director/Board Member | 55 | 31-07-19 | |
Scott Requadt
BRD | Director/Board Member | 56 | 14-01-16 |
David Parkinson
CEO | Chief Executive Officer | 73 | 24-06-15 |
Philip Kantoff
BRD | Director/Board Member | 69 | 13-09-22 |
Ann Thorell
BRD | Director/Board Member | 56 | 31-07-19 |
Gary Sollis
BRD | Director/Board Member | 69 | 26-04-12 |
Lauren Merendino
BRD | Director/Board Member | 49 | 06-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 44 238 147 | 43 230 299 ( 97,72 %) | 0 | 97,72 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,86 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,66 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |